Arcturus Therapeutics Holdings Inc ARCT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date06/05/24 · 52 Week. Arcturus Therapeutics Holdings (ARCT) stock forecast and price target · ARCTArcturus Therapeutics Holdings Inc. (%). As of August 28 AM. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. Arcturus Therapeutics Holdings (ARCT) stock price prediction is USD. The Arcturus Therapeutics Holdings stock forecast is The current price of ARCT is USD — it has decreased by −% in the past 24 hours. Watch Arcturus Therapeutics Holdings Inc. stock price performance more.
This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled. ARCT Stock Overview · Earnings are forecast to grow % per year · Trading at good value compared to peers and industry · Volatile share price over the past 3. According to analysts, ARCT price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Consensus Arcturus Therapeutics Holdings Inc. Equities. ARCT. UST Market Closed - Nasdaq. Other stock markets. Arcturus Therapeutics Holdings is forecast to grow earnings and revenue by % and 33% per annum respectively. EPS is expected to grow by % per annum. Find the latest Arcturus Therapeutics Holdings Inc. (ARCT) stock quote Price/Sales (ttm). Price/Book (mrq). Enterprise Value/Revenue. Arcturus Therapeutics (ARCT) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Discover all the factors affecting Arcturus Therapeutics Holdings's share price. ARCT is currently rated as a Neutral | Stockopedia. A list of analyst ratings for ARCT (ARCT) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ARCT's current price target is $ Learn why top analysts are making this stock forecast for Arcturus Therapeutics at MarketBeat. Is Arcturus Therapeutics Holdings Stock Undervalued? The current Arcturus Therapeutics Holdings [ARCT] share price is $ The Score for ARCT is
Arcturus Therapeutics Holdings stock has received a consensus rating of buy. The average rating score is and is based on 22 buy ratings, 2 hold ratings, and 2. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Arcturus Therapeutics is $ Based on our forecasts, a long-term increase is expected, the "ARCT" stock price prognosis for is USD. The 5 analysts with month price forecasts for ARCT stock have an average target of 65, with a low estimate of 48 and a high estimate of The average. Why Arcturus Therapeutics Stock Was Up 16% Thursday The biotech stock climbed more than $5 a share in early trading Thursday. Cathie Wood. The Arcturus Therapeutics Holdings stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week. 5 Day. % ; 1 Month. % ; 3 Month. % ; YTD. % ; 1 Year. %. On average, Wall Street analysts predict that Arcturus Therapeutics Holdings's share price could reach $ by Aug 12, The average Arcturus Therapeutics.
Stock price target for Arcturus Therapeutics Ltd. ARCT are on downside and on. Tomorrow Target 1, Tomorrow Target 2, Tomorrow Target 3. The average price target is $ with a high estimate of $ and a low estimate of $ The average one-year price target for Arcturus Therapeutics Holdings Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. Arcturus Therapeutics Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ARCT updated stock price target summary. ARCT Price · $ ; Market Cap · $M ; 52 Week Low · $ ; 52 Week High · $ ; P/E · x.
The share price as of September 6, is / share. Previously, on September 7, , the share price was / share. This represents a decline of. While ratings are subjective and will change, the latest Arcturus Therapeutics (ARCT) rating was a reiterated with a price target of $ to $ The.
How To Find The Best Realtor To Buy A House | What Is Business Process Optimization